Gleason-score
发表于 2025-3-26 22:25:32
http://reply.papertrans.cn/67/6652/665162/665162_31.png
光滑
发表于 2025-3-27 03:51:33
Michael D. Green,Peggy Alderton,Mordechai M. Sobol,Janet Gross,Franco M. Muggia,James L. Speyericht in “langwierigen” Gesprächen von der Eignung der Instrumente zu überzeugen hat — der Forschungs- und Entwicklungs-Controller kann auf das Setzen deutlicher Signale seitens der Geschäftsführung verweisen. Ferner sind Bereichs- oder Abteilungsleiter dazu angehalten, sich kritisch mit den Instrume
使坚硬
发表于 2025-3-27 07:02:02
Nikhil C. Munshi,Patrick J. Loehrer,Stephen D. Williamsicht in “langwierigen” Gesprächen von der Eignung der Instrumente zu überzeugen hat — der Forschungs- und Entwicklungs-Controller kann auf das Setzen deutlicher Signale seitens der Geschäftsführung verweisen. Ferner sind Bereichs- oder Abteilungsleiter dazu angehalten, sich kritisch mit den Instrume
厚颜无耻
发表于 2025-3-27 09:40:33
http://reply.papertrans.cn/67/6652/665162/665162_34.png
无辜
发表于 2025-3-27 14:00:55
ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: Clinical and preclcess, selectively abrogated the toxic cardiomyopathy caused by anthracyclines without adversely affecting the antitumor response indicates that there must be different mechanisms of anthracycline action, either in different tissues and/or in malignant versus non-malignant cells.
Chagrin
发表于 2025-3-27 21:21:38
Thierry Le Chevalier,Rodrigo Arriagada,Maurice Tubiana
小卒
发表于 2025-3-28 00:03:35
New Drugs, Concepts and Results in Cancer Chemotherapy
情感
发表于 2025-3-28 05:24:05
Modulation of the activity of cancer chemotherapeutic agents by dipyridamolepyridamole can modulate the activity of a number of chemotherapeutic agents and may have the ability to enhance their therapeutic index. We review here the cellular and biochemical mechanisms by which dipyridamole alters cancer cell sensitivity and point out potential clinical applications.
傻瓜
发表于 2025-3-28 09:25:41
Folate antimetabolites inhibitory to , purine synthesiserim and that the potential of folate antimetabolites as therapeutic agents is established.Of course, the pharmaceutical promise for a new class of folate antimetabolites also continues to be high, given the central nature of the folate-dependent enzymes in processes required for any proliferative cell population.
acetylcholine
发表于 2025-3-28 11:54:56
Uroprotection in patients receiving cyclophosphamide and ifosfamiden has been designing agents that are pharmacologically noncytotoxic but control or prevent toxic side effects of an administered cytotoxic agent. These protective agents allow administration of presently available agents at much higher doses.